88 related articles for article (PubMed ID: 445515)
1. Mycosis fungoides: epidemiologic observations.
Greene MH; Dalager NA; Lamberg SI; Argyropoulos CE; Fraumeni JF
Cancer Treat Rep; 1979 Apr; 63(4):597-606. PubMed ID: 445515
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of possible causative factors in mycosis fungoides.
Tuyp E; Burgoyne A; Aitchison T; MacKie R
Arch Dermatol; 1987 Feb; 123(2):196-200. PubMed ID: 3813592
[TBL] [Abstract][Full Text] [Related]
3. Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sézary syndrome.
Fischmann AB; Bunn PA; Guccion JG; Matthews MJ; Minna JD
Cancer Treat Rep; 1979 Apr; 63(4):591-6. PubMed ID: 445514
[TBL] [Abstract][Full Text] [Related]
4. Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma.
Schmidt AN; Robbins JB; Greer JP; Zic JA
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S202-5. PubMed ID: 16631940
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides in Norway 1960-80. A retrospective study.
McFadden N; Nyfors A; Tanum G; Granholt A; Helme P; Kavli G
Acta Derm Venereol Suppl (Stockh); 1983; 109():1-13. PubMed ID: 6589937
[TBL] [Abstract][Full Text] [Related]
6. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe).
Morales-Suárez-Varela MM; Olsen J; Johansen P; Kaerlev L; Guénel P; Arveux P; Wingren G; Hardell L; Ahrens W; Stang A; Llopis A; Merletti F; Aurrekoetxea JJ; Masala G
Cancer Causes Control; 2005 Dec; 16(10):1253-9. PubMed ID: 16215876
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
8. Occupational risk factors for mycosis fungoides: a European multicenter case-control study.
Morales-Suárez-Varela MM; Olsen J; Johansen P; Kaerlev L; Guénel P; Arveux P; Wingren G; Hardell L; Ahrens W; Stang A; Llopis A; Merletti F; Aurrekoetxea JJ; Masala G
J Occup Environ Med; 2004 Mar; 46(3):205-11. PubMed ID: 15091282
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of mycosis fungoides.
Weinstock MA
Semin Dermatol; 1994 Sep; 13(3):154-9. PubMed ID: 7986682
[TBL] [Abstract][Full Text] [Related]
10. Plutonium-induced mycosis fungoides and parapsoriasis en plaques--a new entity?
Zachariae H; Søgaard H
Curr Probl Dermatol; 1990; 19():81-9. PubMed ID: 2298035
[No Abstract] [Full Text] [Related]
11. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
12. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
[TBL] [Abstract][Full Text] [Related]
13. [Conjugal mycosis fungoides].
Dupin M; Darie H; Jumbou O; Veran Y; Gros P; Dreno B; Dormont D; Millet P
Ann Dermatol Venereol; 1995; 122(9):595-8. PubMed ID: 8745682
[TBL] [Abstract][Full Text] [Related]
14. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
[TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides.
Väkevä L; Sarna S; Vaalasti A; Pukkala E; Kariniemi AL; Ranki A
Acta Derm Venereol; 2005; 85(4):318-23. PubMed ID: 16191852
[TBL] [Abstract][Full Text] [Related]
17. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
18. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
19. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.
Gahongayire F
Int J Dermatol; 2007 Oct; 46 Suppl 1():32-5. PubMed ID: 17919204
[TBL] [Abstract][Full Text] [Related]
20. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
